Related Experiment Videos
Sampling error in diagnosing hyperparathyroid changes in bone in small needle biopsies
The American Journal of Surgical Pathology
|February 1, 1986
Summary
Diagnosing secondary hyperparathyroidism requires large-core bone biopsies. Smaller biopsy samples significantly increase the risk of missing this bone disease diagnosis in hemodialysis patients.
Area of Science:
- Nephrology
- Histopathology
- Bone Metabolism
Background:
- Secondary hyperparathyroidism is a common complication in hemodialysis patients.
- Accurate diagnosis of bone disease effects is crucial for patient management.
Purpose of the Study:
- To evaluate the impact of bone biopsy sample size on diagnosing secondary hyperparathyroidism.
- To determine the diagnostic accuracy of different bone biopsy core diameters.
Main Methods:
- Retrospective analysis of large-core bone biopsy samples (mean width 5 mm) from 10 hemodialysis patients.
- Histological evaluation using intratrabecular osteoclastic tunneling resorption as the diagnostic marker.
- Subdividing samples to simulate smaller biopsy instruments (e.g., Jamshidi needle).
Main Results:
- A 30% diagnostic miss rate for secondary hyperparathyroidism if using a Jamshidi-type needle.
- A 60% diagnostic miss rate if using a needle with a 1.6 mm core diameter.
- Significant underdiagnosis potential with smaller biopsy sizes.
Conclusions:
- Large-core bone biopsies are essential for accurate diagnosis of secondary hyperparathyroidism.
- Smaller biopsy instruments may lead to missed diagnoses of metabolic bone diseases.
- Utilizing adequate sample size is critical in bone histopathology.